EditorJ

Trimtech Therapeutics establishes scientific advisory board

NICE recommends Tremfya for moderately to severely active Crohn’s disease and ulcerative colitis

FDA approves first new fibromyalgia therapy in over 15 years

Reimbursement price for Haemophilia B gene therapy

Additional clinical data submitted to the US FDA on an oral SGLT1/SGLT2 inhibitor

Clinical data on Pilavapadin was presented in San Diego

Italian Medicines Agency approves Hemgenix

PhoreMost appoints Dr Adam Gilbert to scientific advisory board

Strategic partnership to launch an AI-powered platform for accelerated peptide drug discovery

New data to address evidence gaps in access to medicines